Treatment of prostatic cancer by intramuscular administration and intratumor injection of peplomycin

Treatment of prostatic cancer by intramuscular administration and intratumor injection of peplomycin

Peplomycin, a new derivative of Bleomycin, was evaluated clinically for treatment of prostate cancer patients. Peplomycin was injected intramuscularly, 5 or 10 mg every other day, to 8 patients with prostate cancer. Total dose ranged from 30 to 200 mg. According to Karnofsky's criteria, only on...

Ausführliche Beschreibung

Bibliographische Detailangaben
Veröffentlicht in:Hinyokika kiyo. Acta urologica Japonica. - 1962. - 29(1983), 11 vom: 30. Nov., Seite 1433-41
1. Verfasser: Fujimoto, Y (VerfasserIn)
Weitere Verfasser: Okano, M, Takeuchi, T, Saito, A, Fujihiro, S, Kuriyama, M, Sakai, S, Nishiura, T
Format: Aufsatz
Sprache:Japanese
Veröffentlicht: 1983
Zugriff auf das übergeordnete Werk:Hinyokika kiyo. Acta urologica Japonica
Schlagworte:Case Reports Comparative Study English Abstract Journal Article Antibiotics, Antineoplastic Bleomycin 11056-06-7 Peplomycin 56H9L80NIZ